Whitebox Advisors LLC lowered its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) by 36.9% during the 1st quarter, Holdings Channel.com reports. The firm owned 29,955 shares of the company’s stock after selling 17,500 shares during the quarter. Whitebox Advisors LLC’s holdings in Acadia Healthcare were worth $701,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds also recently made changes to their positions in the business. Goldman Sachs Group Inc. boosted its position in shares of Acadia Healthcare by 417.8% during the fourth quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock worth $67,099,000 after buying an additional 3,815,471 shares during the period. Jefferies Financial Group Inc. acquired a new stake in Acadia Healthcare in the 4th quarter valued at approximately $47,960,000. Wellington Management Group LLP raised its stake in Acadia Healthcare by 24.9% during the 4th quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock valued at $167,077,000 after acquiring an additional 2,350,760 shares in the last quarter. Vaughan Nelson Investment Management L.P. bought a new position in shares of Acadia Healthcare in the first quarter worth $43,017,000. Finally, Invenomic Capital Management LP grew its stake in shares of Acadia Healthcare by 71.0% in the fourth quarter. Invenomic Capital Management LP now owns 3,312,043 shares of the company’s stock worth $46,998,000 after purchasing an additional 1,375,647 shares in the last quarter.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently weighed in on the stock. Guggenheim lifted their price objective on shares of Acadia Healthcare from $26.00 to $31.00 and gave the company a “buy” rating in a research note on Monday, May 4th. TD Cowen boosted their price target on shares of Acadia Healthcare from $30.00 to $36.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Royal Bank Of Canada upped their price target on shares of Acadia Healthcare from $28.00 to $31.00 and gave the stock an “outperform” rating in a research note on Monday, May 4th. Barclays increased their price objective on shares of Acadia Healthcare from $20.00 to $25.00 and gave the company an “equal weight” rating in a report on Thursday, April 30th. Finally, Cantor Fitzgerald lifted their price target on Acadia Healthcare from $20.00 to $30.00 and gave the company a “neutral” rating in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $28.69.
Acadia Healthcare Stock Performance
Shares of ACHC opened at $34.51 on Monday. The firm’s 50 day moving average is $27.64 and its 200-day moving average is $23.24. The stock has a market capitalization of $3.17 billion, a P/E ratio of -2.82, a P/E/G ratio of 11.51 and a beta of 0.64. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.71. Acadia Healthcare Company, Inc. has a 12-month low of $11.43 and a 12-month high of $35.83.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last released its earnings results on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.28 by $0.09. The business had revenue of $828.80 million during the quarter, compared to analyst estimates of $823.51 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The business’s quarterly revenue was up 7.6% on a year-over-year basis. During the same period in the prior year, the business earned $0.40 earnings per share. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Equities research analysts anticipate that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current fiscal year.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.
Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.
Featured Articles
- Five stocks we like better than Acadia Healthcare
- RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
- These 4 Earnings Reports Expose the Market’s Growing Economic Divide
- Broadcom May Be the Biggest Winner From Alphabet’s Earnings
- Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report).
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
